The spread has widened to 8% due to regulatory approval concerns. Regulatory approval should be forthcoming as the transaction involves Chinese entities acquiring a Chinese-focused company.
What is covered in the Full Insight:
Transaction Delay Explanation
Closing Conditions Status
Chinese Regulatory Approvals Introduction
NDRC, MOFCOM and SAFE Procedures
Reasons why regulatory approvals should be forthcoming